抗苗勒管激素水平与早期自然绝经发生率的前瞻性研究
在护士健康研究II前瞻性队列的巢式病例对照研究中,1996-1999年采集绝经前血样,随访至2011年。AMH每降低0.10 ng/ml,早期绝经风险升高14%(95%CI 1.10-1.18;P<0.001);AMH为1.5、1.0、0.5 ng/ml者相较2.0 ng/ml的OR分别为2.6、7.5、23(均P<0.001)。
要点
- AMH每降低0.10 ng/ml,早期绝经风险升高14%(95%CI 1.10-1.18;P<0.001)。
- AMH为1.5、1.0、0.5 ng/ml者相较2.0 ng/ml的OR分别为2.6、7.5、23(均P<0.001)。
- AMH预测早期绝经的C统计量从0.68(年龄≤35)到0.93(年龄42)。
核心结论
- 观察到较低的AMH水平与较高的早期绝经风险之间存在强且显著的关联。
- 作者认为这些发现支持AMH作为其他方面健康女性早期绝经的临床标志物。
研究设计与样本
- 前瞻性护士健康研究II队列内的巢式病例对照研究,1996-1999年采集绝经前血样,随访至2011年,随访率>94%。
- 早期绝经病例327例为采血后至45岁前报告自然绝经的女性;对照491例为45岁后绝经的女性,其中327例按采血年龄(±4个月)及其他因素与病例匹配。
- AMH水平在2016年检测,检测时间距早期绝经最长可达12年。
主要发现
- 在多变量条件logistic回归模型中(调整匹配因素、体重指数、吸烟、产次、口服避孕药使用及其他因素),AMH每降低0.10 ng/ml,早期绝经风险升高14%(95%CI 1.10-1.18;P<0.001)。
- 在包含AMH线性项和二次项的多项式回归模型中,AMH为1.5、1.0、0.5 ng/ml的女性相较2.0 ng/ml的早期绝经OR分别为2.6、7.5、23(均P<0.001)。
- 无论吸烟状态、肥胖程度、不孕史和月经周期特征如何,均观察到显著关联。
- 评估AMH预测能力的模型显示高度一致性,C统计量较高,从0.68(年龄≤35)到0.93(年龄42)。
关键数值与推荐
- AMH每降低0.10 ng/ml,早期绝经风险升高14%(95%CI 1.10-1.18;P<0.001)。
- AMH为1.5、1.0、0.5 ng/ml的女性相较2.0 ng/ml的早期绝经OR分别为2.6、7.5、23(均P<0.001)。
- C统计量从0.68(年龄≤35)到0.93(年龄42)。
临床怎么用
- 作者认为这些发现支持AMH作为其他方面健康女性早期绝经的临床标志物。
局限性
- 研究人群在种族/民族方面相对同质,需要在更多样化的人群中进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are anti-Müllerian hormone (AMH) levels assessed in women aged 32-44 associated with risk of incident early natural menopause? SUMMARY ANSWER: We observed strong, significant associations between lower AMH levels and higher risk of early menopause. WHAT IS KNOWN ALREADY: The ability to predict risk early menopause, defined as menopause before age 45, prior to fertility decline would improve options for family planning and cardiovascular disease prevention. Though AMH is an established marker of menopause timing in older reproductive-aged women, whether AMH is associated with risk of early menopause has not been evaluated. STUDY DESIGN, SIZE, DURATION: We assessed these relations in a nested case-control study within the prospective Nurses' Health Study II cohort. Premenopausal blood samples were collected in 1996-1999. Participants were followed until 2011 for early natural menopause, with follow-up rates >94%. PARTICIPANTS/MATERIALS, SETTING, METHODS: Early menopause cases (n = 327) were women reporting natural menopause between blood collection and age 45. Controls (n = 491) experienced menopause after age 45 and included 327 cases matched to controls on the basis of age at blood draw (±4 months) and other factors. AMH levels up to 12 years before early menopause were assayed in 2016. MAIN RESULTS AND THE ROLE OF CHANCE: In multivariable conditional logistic regression models adjusting for matching factors, body mass index, smoking, parity, oral contraceptive use, and other factors, each 0.10 ng/ml decrease in AMH was associated with a 14% higher risk of early menopause (95% confidence interval (CI) 1.10 to 1.18; P < 0.001). In polynomial regression models including linear and quadratic terms for AMH, odds ratios for early menopause for women with AMH levels of 1.5, 1.0 and 0.5 ng/ml compared to 2.0 ng/ml were 2.6, 7.5 and 23 (all P < 0.001). Significant associations were observed irrespective of smoking status, adiposity, infertility history and menstrual cycle characteristics. Furthermore, models assessing the predictive ability of AMH showed high concordance, and C-statistics were high, ranging from 0.68 (age ≤35) to 0.93 (age 42). LIMITATIONS, REASONS FOR CAUTION: Our population was relatively homogenous with respect to race/ethnicity. Further work in more ethnically diverse populations is needed. WIDE IMPLICATION OF THE FINDINGS: To our knowledge, this is the first prospective study to evaluate whether AMH levels are associated with early menopause. These findings support the utility of AMH as a clinical marker of early menopause in otherwise healthy women. STUDY FUNDING/COMPETING INTEREST(S): This project was supported by UM1CA176726, R01CA67262, and R01HD078517 from the U.S. Department of Health and Human Services, National Institutes of Health. No competing interests declared.
引用
- Bertone-Johnson ER, Manson JE, Purdue-Smithe AC, et al. Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study. Hum Reprod. 2018. PMID: 29659835. doi:10.1093/humrep/dey077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。